CAM
TRIL

Cormorant Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Cormorant Asset Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
2020
Q3 		$35.5M Buy
2018
Q4 		– Sell
2018
Q3 		$2.9M Sell
2018
Q2 		$3.44M Hold
2018
Q1 		$4.13M Sell
2017
Q4 		$4.38M Hold
2017
Q3 		$3.09M Hold
2017
Q2 		$2.64M Buy